Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 184.50
-5.50 (-2.89%)
Dec 23, 2025, 1:30 PM CST
Lumosa Therapeutics Market Cap
Lumosa Therapeutics has a market cap or net worth of 31.08 billion as of December 23, 2025. Its market cap has decreased by -49.74% in one year.
Market Cap
31.08B
Enterprise Value
30.26B
Revenue
42.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
184.50
Market Cap Chart
Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 31.08B, an increase of 623.68%. That is a compound annual growth rate of 20.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 31.08B | -26.39% |
| Dec 31, 2024 | 42.22B | 274.74% |
| Dec 29, 2023 | 11.27B | 75.37% |
| Dec 30, 2022 | 6.43B | 5.04% |
| Dec 30, 2021 | 6.12B | 17.77% |
| Dec 31, 2020 | 5.19B | 28.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 249.69B |
| PharmaEssentia | 183.44B |
| Heron Neutron Medical | 79.65B |
| Lotus Pharmaceutical | 75.08B |
| Bora Pharmaceuticals Co., LTD. | 61.84B |
| Lin BioScience | 33.05B |
| Oneness Biotech | 28.18B |
| Center Laboratories | 28.11B |